Resolute Science Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.92M
- Investors
-
5
Resolute Science General Information
Description
Developer of targeted cancer therapeutics designed for the treatment of aggressive solid tumors. The company's platform develops synthetic drug conjugates using a macrophage-targeted delivery approach that leverages tumor-associated macrophages to process and distribute cytotoxic or radiotherapeutic payloads within tumors, supports a pipeline of preclinical drug candidates, enabling healthcare professionals to overcome resistance mechanisms and improve treatment options for patients with hard-to-treat cancers.
Contact Information
Website
www.resolutescience.comCorporate Office
- 3210 Merryfield Row
- San Diego, CA 92121
- United States
Corporate Office
- 3210 Merryfield Row
- San Diego, CA 92121
- United States
Resolute Science Timeline
Resolute Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 03-Apr-2026 | $2.92M | Completed | Pre-Clinical Trials | ||
| 7. Later Stage VC | 11-Sep-2024 | Completed | Generating Revenue | |||
| 6. Grant | 24-Sep-2024 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 26-May-2024 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 08-Apr-2024 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 03-Nov-2023 | Completed | Pre-Clinical Trials | |||
| 2. Capitalization | $2.03M | $2.03M | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Resolute Science Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Resolute Science Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Resolute Science Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NuFund Venture Group | Angel Group | |||
| Curebound | Not-For-Profit Venture Capital | |||
| TL Foundation | Not-For-Profit Venture Capital | |||
| CONNECT (San Diego) | Accelerator/Incubator | |||
| National Cancer Institute | Government |
Resolute Science FAQs
-
When was Resolute Science founded?
Resolute Science was founded in 2020.
-
Where is Resolute Science headquartered?
Resolute Science is headquartered in San Diego, CA.
-
What is the size of Resolute Science?
Resolute Science has 8 total employees.
-
What industry is Resolute Science in?
Resolute Science’s primary industry is Drug Discovery.
-
Is Resolute Science a private or public company?
Resolute Science is a Private company.
-
What is Resolute Science’s current revenue?
The current revenue for Resolute Science is .
-
How much funding has Resolute Science raised over time?
Resolute Science has raised $7M.
-
Who are Resolute Science’s investors?
NuFund Venture Group, Curebound, TL Foundation, CONNECT (San Diego), and National Cancer Institute have invested in Resolute Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
